Promising results of studies of this marker in adults with various kidney diseases, but also in children with urinary tract defects, suggest that MCP-1 could be a potential biomarker for the assessment of early kidney damage also in children with a single functioning kidney. This evidence concerns the gene CCL2 and Nephropathy.